<?xml version="1.0" encoding="UTF-8" standalone="yes"?><Drug id="72261" name="IL13-HSVTK suicide gene therapy (sleeping beauty transposon, brain tumor), Discovery genomics"><HDS>Discovery</HDS><Actions><Action id="20464" type="primary">Interleukin 13 ligand</Action><Action id="1509" type="primary">Thymidine kinase modulator</Action><Action id="1589" type="secondary">Apoptosis stimulator</Action><Action id="4793" type="secondary">Unspecified non-viral vector based gene therapy</Action><Action id="1545" type="secondary">Anticancer</Action></Actions><Indications><Indication id="760" type="primary">Brain tumor</Indication></Indications><Entities><Entity>Biological</Entity></Entities><OriginatorCompany id="20626">University of Minnesota</OriginatorCompany></Drug>